Search

everythinglearnresearchcommunity

for

Search:↓

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Active vitamin D3 might protect hair follicles from radiation damage.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Silastic-Dacron strips effectively prevent stretch-back after hair reduction surgeries.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

New techniques and findings in dermatologic surgery show improved pain management, safer liposuction, better hair transplantation, and effective treatments for skin conditions.

Using tissue adhesive in hair transplants improves results and patient satisfaction, with fewer complications.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.